Correlation Engine 2.0
Clear Search sequence regions

  • humans (1)
  • ligand (3)
  • mass (11)
  • mGlu5 (6)
  • receptor (3)
  • Sizes of these terms reflect their relevance to your search.

    Mass spectrometry (MS) binding assays are a label-free alternative to radioligand or fluorescence binding assays, so the readout is based on direct mass spectrometric detection of the test ligand. The study presented here describes the development and validation of a highly sensitive, rapid, and robust MS binding assay for the quantification of the binding of the metabotropic glutamate 5 (mGlu5) negative allosteric modulator (NAM), MPEP (2-methyl-6-phenylethynylpyridine) at the mGlu5 allosteric binding site. The LC-ESI-MS/MS (liquid chromatography-electrospray ionization-tandem mass spectrometric) analytical method was established and validated with a deuterated analogue of MPEP as an internal standard. The developed MS binding assay described here allowed for the determination of MS binding affinity estimates that were in agreement with affinity estimates obtained from a tritiated MPEP radioligand saturation binding assay, indicating the suitability of this methodology for determining affinity estimates for compounds that target mGlu5 allosteric binding sites. Graphical abstract.


    Maria Ricart-Ortega, Alice E Berizzi, Juanlo Catena, Fanny Malhaire, Lourdes Muñoz, Carmen Serra, Guillaume Lebon, Cyril Goudet, Amadeu Llebaria. Development and validation of a mass spectrometry binding assay for mGlu5 receptor. Analytical and bioanalytical chemistry. 2020 Sep;412(22):5525-5535

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32564119

    View Full Text